Regulations.gov document
Reference 4 Evaluation of How Best to Communicate with Healthcare Providers about the…
Supporting & Related Material · FDA-2006-N-0515 · posted Dec 30, 2014
Key facts
| Document ID | FDA-2006-N-0515-0091 |
|---|---|
| Title | Reference 4 Evaluation of How Best to Communicate with Healthcare Providers about the Risks and Benefits of Prescription Drug Use for Pregnant and Nursing Women A Mental Models Research Report Final Report re Ref2 Final Regulatory Impact Analysis for Docket No. FDA-2006-N-0515 (formerly Docket No. 2006N-0467) |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2006-N-0515 |
| Posted | Dec 30, 2014 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: